Concurrent Session 1B: Advancing Implementation of the National Hepatitis B and Hepatitis C Strategies
Tracks
Track 2
| Wednesday, August 12, 2026 |
| 3:45 PM - 5:15 PM |
| Pleiades |
Details
The Australian Government released the Fourth National Hepatitis B Strategy 2025–2026 and the Sixth National Hepatitis C Strategy 2025–2026 in March 2026. Covering the period from now until 2030, the Strategies are an important roadmap for how Australia can meet its elimination goals for hepatitis B and hepatitis C. But a roadmap is one thing—implementing these ambitious policy documents is another.
This session will bring together leaders from across the national responses to hepatitis B and hepatitis C to reflect on the publication of the Strategies and their respective priorities for implementation. Each panellist will give a brief presentation on implementation of the Strategies, followed by a panel discussion and Q&A.
The session will also include an update on the process to develop Implementation Action Plans for the National Hepatitis B and Hepatitis C Strategies.
Speaker
Ms Lucy Clynes
Ceo
Hepatitis Australia
Welcome and Introduction
3:45 PM - 3:50 PMBiography
Lucy Clynes is the CEO of Hepatitis Australia - the peak community organisation to progress national action on issues of importance to people affected by hepatitis B and hepatitis C.
Lucy has extensive peak body governance experience and a track record of building strategic partnerships to achieve policy and funding outcomes. She was previously a practicing lawyer and held policy positions in both state and federal government, including serving as Deputy Chief of Staff to a government minister.
Mr Jack Wallace
Senior Research Officer
Burnet Institute
Welcome and Introduction
3:45 PM - 3:50 PMBiography
Jack has worked across community, government and research sectors to reduce the personal and community impacts of blood borne viruses, particularly viral hepatitis. Prior to his research career, he established Hepatitis Australia, the national peak organisation representing people living with viral hepatitis, serving as Executive Officer from 1998 to 2005.
Mr Benjamin Riley
Senior Policy Analyst
Hepatitis Australia
An update on the implementation planning process for the National Hepatitis B and C Strategies
3:50 PM - 4:05 PMBiography
Benjamin Riley is the Senior Policy Analyst at Hepatitis Australia. He is a public health policy expert with extensive experience in the Australian blood-borne virus, sexual health and LGBTIQA+ health sectors, at organisations including ASHM, Thorne Harbour Health and the Victorian Pride Lobby.
Along with his policy experience, Benjamin has a background in journalism, LGBTIQA+ community advocacy, and social research focusing on gay men, HIV and the cultural legacies of AIDS.
Dr Glen Hornby
Assistant Director - Sti Section
Australian CDC
The Australian CDC's priorities for implementing the National Strategies
4:05 PM - 4:15 PMBiography
Glen is an assistant director at the Australian CDC, in the STI Section. Previous professional experience includes working at the Department of Health, Department of Foreign Affairs and Trade, the National Indigenous Australians Agency, and at Griffith University. Glen has extensive experience working in the Pacific, including the Solomon Islands, Nauru and Kiribati.
Mx Joël Murray
Policy And Evaluation Specialist
AIVL—Australian Injecting and Illicit Drug User League
Peer-based harm reduction and drug user organisations' priorities for implementing the National Strategies
4:15 PM - 4:25 PMBiography
Joël has over 15 years of experience in non-profit management and program delivery, focusing on peer-led services implementation and key populations policy and research in Australia, Europe, Asia, and The Pacific.
Ms Monica Kempster
Director, Sexual Health and BBVs
NACCHO
Aboriginal and Torres Strait Islander community-controlled health organisations' priorities for implementing the National Strategies
4:25 PM - 4:35 PMBiography
Monica Kempster is the Director of Sexual Health and Blood Borne Viruses at NACCHO, leading national initiatives that support Aboriginal Community Controlled Health Organisations to improve sexual health and blood-borne virus outcomes for Aboriginal and Torres Strait Islander peoples. Drawing on extensive experience across public health, data and analytics, and government leadership, Monica is passionate about using evidence, partnerships, and innovation to deliver better outcomes for communities.
A/Prof Thomas Tu
Group Leader
University Of Sydney And Westmead Institute For Medical Research
Priorities for implementing the National Strategies for people living with hepatitis B
4:35 PM - 4:45 PMBiography
A/Prof Thomas Tu leads the Hepatitis B research group at the Westmead Institute for Medical Research and is a world leader Hepatitis B virology. Drawing on lived experience of hepatitis B, he is committed to translational research that improves outcomes for affected communities.
Ms Jessica Michaels
Deputy CEO
ASHM Health
Clinical workforce priorities for implementing the National Strategies
4:45 PM - 4:55 PMBiography
Jessica Michaels is the Deputy CEO at ASHM. Jessica's work at ASHM includes overseeing the implementation of HIV, sexual health, hepatitis C and hepatitis B workforce development, capacity building, resources, strategies and policies across Australia.
Ms Mish Pony
CEO
Scarlet Alliance, Australian Sex Workers Association
Peer-based sex worker organisations' priorities for implementing the National Strategies
4:55 PM - 5:05 PMBiography
Mish Pony (they/them) is Chief Executive Officer of Scarlet Alliance, Australian Sex Workers Association, the national peak body representing sex workers and sex worker organisations across Australia. With over a decade of experience in advocacy and governance, Mish has held multiple roles within Scarlet Alliance, including as the organisation's Trans and Gender Diverse Representative and Chief Operations Officer, before stepping into the CEO role.
Mish's work centres on the intersection of sex worker rights, social justice and health equity, including advocacy on HIV and BBV prevention, decriminalisation, and the impacts of online content regulation on sex workers' access to health information and peer support. They have presented at conferences including the World Association for Sexual Health Congress (WAS2025) and ASHM's HIV & Sexual Reproductive Health Conference, and contribute regularly to public commentary through outlets such as Overland and Archer Magazine on sex work, censorship, and queer politics.
VH2026
Q&A
5:10 PM - 5:15 PMBiography
Chairperson
Lucy Clynes
Ceo
Hepatitis Australia
Jack Wallace
Senior Research Officer
Burnet Institute